Evidence map›Paper›PMID 24024147›Full record

ReviewRedox biology2013

The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysis.

Corinne M Spickett

Abstract readReview
In one paragraph

Review in Redox biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed.

  1. Article
  2. Antimicrobial Peptide CPP-C3M4 AttenuatesAnimals : an open access journal from MDPI · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Reactive oxygen species in the pathogenesis of sarcopenia.Free radical biology & medicine · 2025
    Review
  19. Article
  20. Review

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Corinne M SpickettSchool of Life and Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

4-Hydroxy-2-nonenal (HNE) is one of the most studied products of phospholipid peroxidation, owing to its reactivity and cytotoxicity. It can be formed by several radical-dependent oxidative routes involving the formation of hydroperoxides, alkoxyl radicals, epoxides, and fatty acyl cross-linking reactions. Cleavage of the oxidized fatty acyl chain results in formation of HNE from the methyl end, and 9-oxo-nonanoic acid from the carboxylate or esterified end of the chain, although many other products are also possible. HNE can be metabolized in tissues by a variety of pathways, leading to detoxification and excretion. HNE-adducts to proteins have been detected in inflammatory situations such as atherosclerotic lesions using polyclonal and monoclonal antibodies, which have also been applied in ELISAs and western blotting. However, in order to identify the proteins modified and the exact sites and nature of the modifications, mass spectrometry approaches are required. Combinations of enrichment strategies with targetted mass spectrometry routines such as neutral loss scanning are now facilitating detection of HNE-modified proteins in complex biological samples. This is important for characterizing the interactions of HNE with redox sensitive cell signalling proteins and understanding how it may modulate their activities either physiologically or in disease.

Indexed as

Lipid PeroxidationAldehydes4-hydroxy-2-nonenalAldehydesAnti-HNE antibodiesDHN-MA, 1,4-Dihydroxynonane-mercapturic acidDNPH, 2,4-DinitrophenylhydrazineESI, Electrospray ionizationFT-ICR, Fourier transform ion cyclotron resonanceHNE, 4-Hydroxy-2-nonenalHNE-protein adductsHODA, 9-Hydroxy-12-oxo-10(E)-dodecenoic acidHPETE, Hydroperoxyeicosatetraenoic acidHPODE, Hydroperoxyoctadecadienoic acidHydroxyalkenalKODA, 9-Keto-12-oxo-10(E)-dodecenoic acidMab, Monoclonal antibodyMALDI, Matrix assisted laser desorption ionizationMass spectrometryMDA, MalondialdehydeMS, Mass spectrometryNeutral loss scanningONA, 9-Oxo-nonanoic acidONE, 9-Oxo-2-nonenalPETE, PeroxyeicosatetraenoatePODE, PeroxyoctadecadienoateRedox signalling

Identifiers

PMID24024147
PMCPMC3757682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.